Phosphoprotein-based Biomarkers as Predictors for Cancer Therapy
A. M. Carter, C. Tan, K. Pozo, R. Telange, R. Molinaro, A. Guo, E. De Rosa, J. O. Martinez, S. Zhang, N. Kumar, M. Takahashi, T. Wiederhold, H. K. Ghayee, S. C. Oltmann, K. Pacak, , J. A. Bibb
The paper identifies phosphoprotein biomarkers for Cdk5 activity in neuroendocrine tumors and shows their predictive value for anti-Cdk5 therapy.
bioRxiv · Jun 20, 2019Cancer Biology